Cancer Research
- Lung Cancer- Even If You Can't Prevent It, There May Be A Better Way To Kill It
-
Among cancer deaths worldwide, l ung cancer is the leader. It isn't just the tumor cells, the growth of blood vessels controls tumors development and blood vessel growth is controlled by several signalling molecules. Scientists have discovered a mole ...
Article - News Staff - Apr 10 2014 - 8:44pm
- A New Way To Fire Up The Body's Immune Cells And Fight Tumors
-
Researchers have uncovered a new way to stimulate activity of immune cell opiate receptors, leading to efficient tumor cell clearance- their pharmacological approach can activate the immune cells to prevent cancer growth through stimulation of the opiate ...
Article - News Staff - May 15 2012 - 11:30am
- Study Results Of Novocure's NovoTTF Chemotherapy-Free Phase 3 Trial Published
-
...
Article - Anna Ohlden - May 21 2012 - 11:04am
- Investigational Anti-PD-1 Immunotherapy BMS-936558 Clinical Activity In Phase 1 Trial For Non-Small-Cell Lung Cancer
-
...
Article - Anna Ohlden - Jun 3 2012 - 9:17pm
- GHSG HD15 Trial:Reduction Of Chemotherapy And PET-Guided Radiotherapy In Advanced-Stage Hodgkin Lymphoma
-
AMSTERDAM, June 15, 2012 -- Results of the German Hodgkin Study Group (GHSG) HD 15 trial were presented at the 17th Congress of the European Hematology Association in Amsterdam. ...
Article - Anna Ohlden - Jun 15 2012 - 11:30am
- How Malignant Cells In Patients With Chronic Lymphocytic Leukemia Escape Recognition And Attack By T Cells
-
T cell activation is essential for immunity including the recognition and killing of abnormal target cells such as cancerous cells. T cell activity is tightly regulated by signaling at the contact site (referred to as the "immune synapse") with ...
Article - Anna Ohlden - Jun 15 2012 - 1:30pm
- Agility Radiation Therapy Treatment For Cancer Receives U.S. 510(k) Clearance
-
Using 160 high-resolution tungsten leaves and dramatically faster leaf movement, Elekta’s new Agility multi-leaf collimator (MLC) radiation therapy treatment for cancer patients recently received 510(k) clearance (K121328) from the U.S. Food and Drug Admin ...
Article - News Staff - Jun 25 2012 - 5:00am
- More Coffee Linked To Lower Risk Of Skin Cancer
-
Want to lower your risk of developing the most common form of skin cancer, basal cell carcinoma? Drink more coffee, says a new study. Basal cell carcinoma is the form of skin cancer most commonly diagnosed in the United States. Even though it is slow-grow ...
Article - News Staff - Jul 2 2012 - 12:14am
- Thapsia Garganica: Mediterranean Weed Compound Kills Tumors
-
A novel anticancer drug is designed to travel, undetected by normal cells, through the bloodstream until it becomes activated by specific cancer proteins. It's basically a sleeper cell for tumors. The drug, called G202, is chemically derived from a ...
Article - News Staff - Jul 9 2012 - 4:48pm
- Medulloblastoma: Mutations In Childhood Brain Tumors Identified
-
Researchers have linked mutations in specific genes to each of the four recognized subtypes of medulloblastoma, the most common malignant brain tumor of children. The discovery provides doctors with potential biomarkers for guiding and individualizing trea ...
Article - News Staff - Jul 22 2012 - 4:00pm